Back to search

Next Clinical Research Organisation Limited

09418105

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

47 The Ridgeway Friern Barnet, London, N11 3LG
Incorporated 02/02/2015

Compliance

Last accounts

31/12/2024

micro entity

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 09/03/2026

Due 23/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Andreas Moschos

director · Since 02/02/2015

PHARMACIST

GREEK · GREECE · Age 67

Olympia Sismani

director · Since 14/05/2015

COMPANY DIRECTOR

GREEK · GREECE · Age 61

Mr Terry David Harvey

director · Since 14/05/2015

ACCOUNTANT

BRITISH · UNITED KINGDOM · Age 61

Also on 12 other boards

Andreas Moschos

director · Since 02/02/2015

Greek · Greece · Age 67

Terry David Harvey

director · Since 14/05/2015

British · United Kingdom · Age 61

Olympia Sismani

director · Since 14/05/2015

Greek · Greece · Age 61

Former

Denis Cornel Lonergan

director · Resigned 14/05/2015

Persons with Significant Control

Olympia Sismani

25–50% shares
25–50% votes

Greek · Greece · Age 61

9 G.Lambraki Str, 14561 Kifissia, Athens

Notified 07/04/2016

Mr Andreas Moschos

25–50% shares
25–50% votes

Greek · Greece · Age 67

47 The Ridgeway, Friern Barnet, London, N11 3LG

Notified 07/04/2016

Change History

status → active
2026-08-21

Active

type → ltd
2026-08-21

Private Limited Company

address line1 → 47 The Ridgeway Friern Barnet
2026-08-21

47 THE RIDGEWAY

post town → London
2026-08-21

LONDON

officer appointed → HARVEY, Terry David
2026-08-21
officer appointed → MOSCHOS, Andreas
2026-08-21
officer appointed → SISMANI, Olympia
2026-08-21

CompanyRankvs 554+ SIC 72110 peers
72

Financial strength59th percentile among SIC peers · 15/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 4.15× · 20/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Ccm Technologies Limited
90
10Bio - Diagnostics Limited
89
554Next Clinical Research Organisation Limited
71
How is this score calculated?
Financial strength15/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£3k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£333k

Working capital

Current Assets

£433k

Current Liabilities

£104k

Fixed Assets

£26k

2avg. employees

Balance Sheet

Assets less current liabilities£359k
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20254.15-£54k
20244.78-£6k
20231.16—

Derived from filed accounts. Not audited figures.